---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/100000000862130.md"
description: "$Moderna(MRNA.US) +177% is validation that mRNA isn’t just for COVID. First Phase 3 cancer win with $Merck(MRK.US) opens a massive new market. And SK Hynix buying back means memory demand is real - $Sandisk(SNDK.US) and $Micron Tech(MU.US) catching that bid makes sense."
datetime: "2026-08-20T03:46:44.000Z"
locales:
  - [en](https://longbridge.com/en/topics/100000000862130.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/100000000862130.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/100000000862130.md)
author: "[EdmundK](https://longbridge.com/en/profiles/15902759.md)"
generator: "portal-rs"
---

# $Moderna(MRNA.US) +177% is validation that mRNA is…


### Related Stocks

- [MRNA.US](https://longbridge.com/en/quote/MRNA.US.md)
- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)
- [SNDK.US](https://longbridge.com/en/quote/SNDK.US.md)
- [MU.US](https://longbridge.com/en/quote/MU.US.md)

## Comments (1)

- **Louis_t · 2026-08-20T04:35:26.000Z**: hynix announced that buyback on a day the stock fell 10%, more a floor under the selloff than a demand signal. hbm sold out into 2028 is the demand part.


---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**